\-\ Texto\\:\\ \ \(0\)\
\-\ vs\\:\\ t\\ 98\\.3\\,\\ b\\/p\\ 97\\/59\\,\\ p\\ 71\\,\\ r\\ 18\\,\\ o2\\ sat\\ 99\\%\\ on\\ ra\\,\\ no\\ pain\ \(0\)\
\-\ gen\\:\\ wd\\/wn\\,\\ alert\\ and\\ cooperative\\ in\\ nad\\.\\ no\\ weight\\ loss\\,\\ nervousness\\,\\ emotional\\ lability\\,\\ fatique\\,\\ tremor\\,\\ palpitations\\,\\ excessive\\ appetite\\;\\ no\\ increased\\ perspiration\\,\\ heat\\ intolerance\\,\\ moist\\/smooth\\/warm\\ skin\\.\ \(0\)\
\-\ heent\\:\\ nc\\/at\\,\\ perrla\\,\\ eomi\\,\\ tm\\ wnl\\,\\ mmm\\,\\ throat\\ pink\\ no\\ hoarseness\\ or\\ stridor\ \(0\)\
\-\ neck\\:\\ \\ mass\\ was\\ located\\ anterior\\,\\ midline\\;\\ non\\-mobile\\,\\ smooth\\,\\ firm\\ and\\ non\\-tender\\.\\ measurements\\:\\ neck\\ girth\\ 41cm\\/diagonal\\ r\\ to\\ l\\ 11\\.5cm\\/diagonal\\ l\\ to\\ r\\ 12cm\\/width\\ 14\\ cm\\ and\\ length\\ 9\\.5cm\\ \ \(0\)\
\-\ chest\\:\\ symmetric\\,\\ no\\ mass\\.\ \(0\)\
\-\ resp\\:\\ cta\\ b\\ no\\ w\\/r\\/r\ \(0\)\
\-\ cv\\:\\ s1s2\\,\\ rrr\\,\\ no\\ murmur\ \(0\)\
\-\ abd\\:\\ soft\\,\\ nt\\/nt\\,\\ no\\ hsm\ \(0\)\
\-\ gu\\:\\ tanner\\ ii\ \(0\)\
\-\ ext\\:\\ cr\\<2sec\ \(0\)\
\-\ neuro\\:\\ a\\/ox3\\,\\ cn\\ ii\\-xii\\ grossly\\ intact\\,\\ good\\ muscle\\ strength\\,\\ reflexes\\ 2\\+\\ ue\\/le\ \(0\)\
\-\ labs\ \(154\)\
\-\ cbc\\:\\ wbc\\ 11\\.1\\/hg\\ 12\\.8\\/htc\\ 37\\.0\\/plt\\ 359\\ \\ n61\\/b0\\/l28\ \(0\)\
\-\ esr\\:\\ 40\ \(0\)\
\-\ ca\\.\\ 9\\.4\\/phos\\.\\ 4\\/3\\/pt\\ 10\\.7\\/inr\\ 1\\.01\\/\\ ptt\\ 31\\.2\ \(0\)\
\-\ free\\ t\\:\\ 1\\.09\ \(0\)\
\-\ tt4\\:\\ 105\ \(0\)\
\-\ tt3\\:\\ 186\ \(0\)\
\-\ tsh\\:\\ 2\\.33\ \(0\)\
\-\ antimicrosomal\\ \\(ama\\)\\:\\ \\>1000\ \(0\)\
\-\ antithyroglobulin\\ \\(ata\\)\\:\\ \\>1000\ \(0\)\
\-\ thyroxin\\ binding\\ globulin\\:\\ 25\ \(0\)\
\-\ neck\\ biopsy\\:\\ papillary\\ thyroid\\ carcinoma\ \(0\)\
\-\ treatment\\ consists\\ of\\ total\\ or\\ near\\-total\\ thyroidectomy\\ and\\ removal\\ of\\ all\\ involved\\ lymph\\ nodes\\.\\ this\\ is\\ usually\\ followed\\ by\\ radioiodine\\ ablation\\ to\\ destroy\\ the\\ residual\\ thyroid\\ remnant\\ and\\ any\\ metastatic\\ tissue\\ left\\ behind\\ after\\ surgery\\.\\ thyroid\\ replacement\\ is\\ then\\ started\\ to\\ suppress\\ tsh\\ and\\ prevent\\ stimulation\\ of\\ residual\\ thyroid\\ tissue\\.\\ since\\ papillary\\ thyroid\\ carcinoma\\ in\\ children\\ is\\ associated\\ with\\ a\\ high\\ rate\\ of\\ recurrence\\ regular\\ interval\\ follow\\-up\\ with\\ serum\\ thyroglobulin\\ levels\\ \\(a\\ tumor\\ marker\\)\\ and\\ radioiodine\\ whole\\ body\\ scans\\ are\\ required\\.\ \(0\)\
\-\ papillary\\ thyroid\\ carcinoma\ \(4\)\
\-\ thyroid\\ neoplasia\ \(0\)\
\-\ \\ \\-\\ benign\ \(2\)\
\-\ \\ \\ \\ \\ \\ \\-\\ adenoma\ \(0\)\
\-\ \\ \\ \\ \\ \\ \\-\\ colloid\\ nodule\ \(0\)\
\-\ \\ \\ \\ \\ \\ \\-\\ teratoma\\ \\(newborn\\)\ \(0\)\
\-\ \\ \\-\\ malignant\ \(1\)\
\-\ \\ \\ \\ \\ \\ \\-\\ papillary\\ adenocarcinoma\ \(0\)\
\-\ \\ \\ \\ \\ \\ \\-\\ follicular\\ carcinoma\ \(0\)\
\-\ \\ \\ \\ \\ \\ \\-\\ mixed\\ papillary\\ and\\ follicular\\ carcinoma\ \(0\)\
\-\ \\ \\ \\ \\ \\ \\-\\ other\\:\\ anaplastic\\,\\ hurthe\\ cell\\,\\ lymphoma\\,\\ sacroma\\,\\ \ \(0\)\
\-\ \\ \\ \\ \\ \\ \\ \\ \\ epithelial\\,\\ metastatic\\ medullary\\ thyroid\\ carcinoma\ \(1\)\
\-\ 11\\ y\\/o\\ girl\\,\\ previously\\ healthy\\,\\ admitted\\ to\\ the\\ pediatric\\ ward\\ for\\ evaluation\\ of\\ large\\ neck\\ mass\\.\\ mother\\ noticed\\ a\\ midline\\ anterior\\ neck\\ mass\\ 8\\ days\\ prior\\ ot\\ admit\\.\\ no\\ fever\\,\\ swelling\\,\\ pain\\ or\\ erythema\\.\\ no\\ change\\ in\\ size\\ or\\ shape\\.\\ no\\ history\\ of\\ acute\\ illness\\ or\\ trauma\\.\\ no\\ exposure\\ to\\ radiation\\.\\ no\\ symptoms\\ of\\ hyper\\-\\ or\\ hypothyroidism\\ and\\ no\\ family\\ history\\ of\\ thyroid\\ disease\\ or\\ tumor\\ syndromes\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ thyroid\\:\\ 0\\.0713140543084217\ \(0\)\
\-\ \\:\\:\\ 0\\.05881520535698031\ \(0\)\
\-\ papillary\\:\\ 0\\.049074452596021396\ \(0\)\
\-\ \\-\\:\\ 0\\.037297638299491565\ \(0\)\
\-\ carcinoma\\:\\ 0\\.0328768461993104\ \(0\)\
\-\ radioiodine\\:\\ 0\\.03108420033896464\ \(0\)\
\-\ neck\\:\\ 0\\.028385103359937585\ \(0\)\
\-\ 1000\\:\\ 0\\.027635602818390444\ \(0\)\
\-\ no\\:\\ 0\\.027253887126364767\ \(0\)\
\-\ r\\:\\ 0\\.026341930933274704\ \(0\)\
\-\ follicular\\:\\ 0\\.025508889563884852\ \(0\)\
\-\ \\,\\:\\ 0\\.02388618225152536\ \(0\)\
\-\ tsh\\:\\ 0\\.021000593457334214\ \(0\)\
\-\ b\\/p\\:\\ 0\\.01994461181892873\ \(0\)\
\-\ 97\\/59\\:\\ 0\\.01994461181892873\ \(0\)\
\-\ wd\\/wn\\:\\ 0\\.01994461181892873\ \(0\)\
\-\ fatique\\:\\ 0\\.01994461181892873\ \(0\)\
\-\ perspiration\\:\\ 0\\.01994461181892873\ \(0\)\
\-\ moist\\/smooth\\/warm\\:\\ 0\\.01994461181892873\ \(0\)\
\-\ 41cm\\/diagonal\\:\\ 0\\.01994461181892873\ \(0\)\
\-\ 11\\.5cm\\/diagonal\\:\\ 0\\.01994461181892873\ \(0\)\
\-\ 12cm\\/width\\:\\ 0\\.01994461181892873\ \(0\)\
\-\ nt\\/nt\\:\\ 0\\.01994461181892873\ \(0\)\
\-\ 11\\.1\\/hg\\:\\ 0\\.01994461181892873\ \(0\)\
\-\ 12\\.8\\/htc\\:\\ 0\\.01994461181892873\ \(0\)\
\-\ 37\\.0\\/plt\\:\\ 0\\.01994461181892873\ \(0\)\
\-\ n61\\/b0\\/l28\\:\\ 0\\.01994461181892873\ \(0\)\
\-\ 9\\.4\\/phos\\:\\ 0\\.01994461181892873\ \(0\)\
\-\ 4\\/3\\/pt\\:\\ 0\\.01994461181892873\ \(0\)\
\-\ 10\\.7\\/inr\\:\\ 0\\.01994461181892873\ \(0\)\
\-\ 1\\.01\\/\\:\\ 0\\.01994461181892873\ \(0\)\
\-\ 1\\.09\\:\\ 0\\.01994461181892873\ \(0\)\
\-\ tt4\\:\\ 0\\.01994461181892873\ \(0\)\
\-\ tt3\\:\\ 0\\.01994461181892873\ \(0\)\
\-\ antimicrosomal\\:\\ 0\\.01994461181892873\ \(0\)\
\-\ antithyroglobulin\\:\\ 0\\.01994461181892873\ \(0\)\
\-\ ata\\:\\ 0\\.01994461181892873\ \(0\)\
\-\ thyroxin\\:\\ 0\\.01994461181892873\ \(0\)\
\-\ globulin\\:\\ 0\\.01994461181892873\ \(0\)\
\-\ near\\-total\\:\\ 0\\.01994461181892873\ \(0\)\
\-\ hurthe\\:\\ 0\\.01994461181892873\ \(0\)\
\-\ sacroma\\:\\ 0\\.01994461181892873\ \(0\)\
\-\ residual\\:\\ 0\\.019189173961371566\ \(0\)\
\-\ lability\\:\\ 0\\.018376405528069125\ \(0\)\
\-\ 2sec\\:\\ 0\\.018376405528069125\ \(0\)\
\-\ a\\/ox3\\:\\ 0\\.018376405528069125\ \(0\)\
\-\ 359\\:\\ 0\\.018376405528069125\ \(0\)\
\-\ 31\\.2\\:\\ 0\\.018376405528069125\ \(0\)\
\-\ 2\\.33\\:\\ 0\\.018376405528069125\ \(0\)\
\-\ t\\:\\ 0\\.017899122260655324\ \(0\)\
\-\ l\\:\\ 0\\.017626866507413456\ \(0\)\
\-\ 98\\.3\\:\\ 0\\.017459063654521243\ \(0\)\
\-\ emotional\\:\\ 0\\.017459063654521243\ \(0\)\
\-\ ue\\/le\\:\\ 0\\.017459063654521243\ \(0\)\
\-\ hyper\\-\\:\\ 0\\.017459063654521243\ \(0\)\
\-\ 9\\.5cm\\:\\ 0\\.016808199237209522\ \(0\)\
\-\ 186\\:\\ 0\\.016808199237209522\ \(0\)\
\-\ binding\\:\\ 0\\.016808199237209522\ \(0\)\
\-\ destroy\\:\\ 0\\.016808199237209522\ \(0\)\
\-\ ot\\:\\ 0\\.016808199237209522\ \(0\)\
\-\ s1s2\\:\\ 0\\.016303349573602712\ \(0\)\
\-\ or\\:\\ 0\\.01586122000621256\ \(0\)\
\-\ admit\\:\\ 0\\.01554210016948232\ \(0\)\
\-\ w\\/r\\/r\\:\\ 0\\.015239992946349916\ \(0\)\
\-\ thyroglobulin\\:\\ 0\\.015239992946349916\ \(0\)\
\-\ nervousness\\:\\ 0\\.014973515490113753\ \(0\)\
\-\ nc\\/at\\:\\ 0\\.014973515490113753\ \(0\)\
\-\ ama\\:\\ 0\\.014973515490113753\ \(0\)\
\-\ suppress\\:\\ 0\\.014973515490113753\ \(0\)\
\-\ midline\\:\\ 0\\.014959864648590594\ \(0\)\
\-\ cooperative\\:\\ 0\\.014735143282743106\ \(0\)\
\-\ mmm\\:\\ 0\\.014735143282743106\ \(0\)\
\-\ hsm\\:\\ 0\\.014322651072802032\ \(0\)\
\-\ tanner\\:\\ 0\\.014322651072802032\ \(0\)\
\-\ non\\-mobile\\:\\ 0\\.014141558973993126\ \(0\)\
\-\ remnant\\:\\ 0\\.014141558973993126\ \(0\)\
\-\ ptt\\:\\ 0\\.013671786655490311\ \(0\)\
\-\ tremor\\:\\ 0\\.013534626877625074\ \(0\)\
\-\ girth\\:\\ 0\\.013534626877625074\ \(0\)\
\-\ ward\\:\\ 0\\.013534626877625074\ \(0\)\
\-\ neoplasia\\:\\ 0\\.01340530919925415\ \(0\)\
\-\ 105\\:\\ 0\\.013166936991883501\ \(0\)\
\-\ thyroidectomy\\:\\ 0\\.013166936991883501\ \(0\)\
\-\ resp\\:\\ 0\\.013056552005074832\ \(0\)\
\-\ palpitations\\:\\ 0\\.01295130310092349\ \(0\)\
\-\ tm\\:\\ 0\\.01295130310092349\ \(0\)\
\-\ hoarseness\\:\\ 0\\.01295130310092349\ \(0\)\
\-\ stridor\\:\\ 0\\.01295130310092349\ \(0\)\
\-\ pink\\:\\ 0\\.012850733502346943\ \(0\)\
\-\ measurements\\:\\ 0\\.012850733502346943\ \(0\)\
\-\ \\>\\:\\ 0\\.012846911831079479\ \(0\)\
\-\ gu\\:\\ 0\\.012662087328276691\ \(0\)\
\-\ ii\\-xii\\:\\ 0\\.012573352683133521\ \(0\)\
\-\ marker\\:\\ 0\\.012573352683133521\ \(0\)\
\-\ perrla\\:\\ 0\\.012487967325706267\ \(0\)\
\-\ anaplastic\\:\\ 0\\.012175409998826589\ \(0\)\
\-\ 99\\:\\ 0\\.012103580364630705\ \(0\)\
\-\ heat\\:\\ 0\\.012103580364630705\ \(0\)\
\-\ ablation\\:\\ 0\\.012103580364630705\ \(0\)\
\-\ intolerance\\:\\ 0\\.012033961227375607\ \(0\)\
\-\ stimulation\\:\\ 0\\.012033961227375607\ \(0\)\
\-\ eomi\\:\\ 0\\.011900837924156301\ \(0\)\
\-\ ext\\:\\ 0\\.011837102908394546\ \(0\)\
\-\ epithelial\\:\\ 0\\.01177511427900967\ \(0\)\
\-\ excessive\\:\\ 0\\.011714778878371296\ \(0\)\
\-\ cr\\:\\ 0\\.011598730701023897\ \(0\)\
\-\ whole\\:\\ 0\\.011383096810063885\ \(0\)\
\-\ colloid\\:\\ 0\\.011383096810063885\ \(0\)\
\-\ appetite\\:\\ 0\\.011332253244787736\ \(0\)\
\-\ hypothyroidism\\:\\ 0\\.011332253244787736\ \(0\)\
\-\ 71\\:\\ 0\\.011186238491082823\ \(0\)\
\-\ o2\\:\\ 0\\.011093881037417087\ \(0\)\
\-\ throat\\:\\ 0\\.011049078713217584\ \(0\)\
\-\ syndromes\\:\\ 0\\.011049078713217584\ \(0\)\
\-\ sat\\:\\ 0\\.011005146392273915\ \(0\)\
\-\ illness\\:\\ 0\\.010758089170633664\ \(0\)\
\-\ mass\\:\\ 0\\.010755303230294702\ \(0\)\
\-\ nad\\:\\ 0\\.010719413982037962\ \(0\)\
\-\ cv\\:\\ 0\\.010719413982037962\ \(0\)\
\-\ gen\\:\\ 0\\.010643992216726668\ \(0\)\
\-\ consists\\:\\ 0\\.010607203707966984\ \(0\)\
\-\ ra\\:\\ 0\\.010571003840667344\ \(0\)\
\-\ noticed\\:\\ 0\\.010571003840667344\ \(0\)\
\-\ newborn\\:\\ 0\\.0105353740737711\ \(0\)\
\-\ cn\\:\\ 0\\.010398214295905863\ \(0\)\
\-\ non\\-tender\\:\\ 0\\.01023769000637581\ \(0\)\
\-\ abd\\:\\ 0\\.01023769000637581\ \(0\)\
\-\ behind\\:\\ 0\\.010206907988150065\ \(0\)\
\-\ grossly\\:\\ 0\\.010146572587511692\ \(0\)\
\-\ cta\\:\\ 0\\.010087804518726033\ \(0\)\
\-\ shape\\:\\ 0\\.010058983193437732\ \(0\)\
\-\ exposure\\:\\ 0\\.010058983193437732\ \(0\)\
\-\ murmur\\:\\ 0\\.010002419161298777\ \(0\)\
\-\ neuro\\:\\ 0\\.00997465877081956\ \(0\)\
\-\ anterior\\:\\ 0\\.00995833856906216\ \(0\)\
\-\ p\\:\\ 0\\.009920139423355621\ \(0\)\
\-\ wnl\\:\\ 0\\.009920139423355621\ \(0\)\
\-\ 2\\+\\:\\ 0\\.009893364632299055\ \(0\)\
\-\ rrr\\:\\ 0\\.009866903003875544\ \(0\)\
\-\ esr\\:\\ 0\\.009789325914557374\ \(0\)\
\-\ metastatic\\:\\ 0\\.00973352671319498\ \(0\)\
\-\ length\\:\\ 0\\.0096898618344191\ \(0\)\
\-\ alert\\:\\ 0\\.009641722923904882\ \(0\)\
\-\ prevent\\:\\ 0\\.009594586980685783\ \(0\)\
\-\ erythema\\:\\ 0\\.009503162685803708\ \(0\)\
\-\ firm\\:\\ 0\\.00948087242235798\ \(0\)\
\-\ interval\\:\\ 0\\.00948087242235798\ \(0\)\
\-\ replacement\\:\\ 0\\.009436940101414312\ \(0\)\
\-\ heent\\:\\ 0\\.009351554743987056\ \(0\)\
\-\ serum\\:\\ 0\\.009330702583116189\ \(0\)\
\-\ pediatric\\:\\ 0\\.009310040855597472\ \(0\)\
\-\ medullary\\:\\ 0\\.009289566114602183\ \(0\)\
\-\ \\;\\:\\ 0\\.009164801757704044\ \(0\)\
\-\ tissue\\:\\ 0\\.009164801757704044\ \(0\)\
\-\ reflexes\\:\\ 0\\.009151207691178357\ \(0\)\
\-\ b\\:\\ 0\\.009113182536616408\ \(0\)\
\-\ teratoma\\:\\ 0\\.00903899741710738\ \(0\)\
\-\ tumor\\:\\ 0\\.009014625799143944\ \(0\)\
\-\ ca\\:\\ 0\\.00900279754980774\ \(0\)\
\-\ scans\\:\\ 0\\.00900279754980774\ \(0\)\
\-\ regular\\:\\ 0\\.008914753621641057\ \(0\)\
\-\ 11\\:\\ 0\\.008846705080380247\ \(0\)\
\-\ symmetric\\:\\ 0\\.008830008005046259\ \(0\)\
\-\ mother\\:\\ 0\\.008830008005046259\ \(0\)\
\-\ nodes\\:\\ 0\\.008732333408066149\ \(0\)\
\-\ healthy\\:\\ 0\\.008716456546847492\ \(0\)\
\-\ cbc\\:\\ 0\\.00863870169729046\ \(0\)\
\-\ started\\:\\ 0\\.008623466330364343\ \(0\)\
\-\ strength\\:\\ 0\\.008578366296652087\ \(0\)\
\-\ 14\\:\\ 0\\.008519598227866429\ \(0\)\
\-\ mixed\\:\\ 0\\.008490776902578125\ \(0\)\
\-\ smooth\\:\\ 0\\.008462318119304688\ \(0\)\
\-\ recurrence\\:\\ 0\\.008434212870439174\ \(0\)\
\-\ 18\\:\\ 0\\.008392698982049588\ \(0\)\
\-\ children\\:\\ 0\\.008351933132496017\ \(0\)\
\-\ adenocarcinoma\\:\\ 0\\.008351933132496017\ \(0\)\
\-\ admitted\\:\\ 0\\.008351933132496017\ \(0\)\
\-\ ii\\:\\ 0\\.008338506129057522\ \(0\)\
\-\ total\\:\\ 0\\.008325158341439449\ \(0\)\
\-\ good\\:\\ 0\\.008272541006226175\ \(0\)\
\-\ 40\\:\\ 0\\.008133852033683652\ \(0\)\
\-\ previously\\:\\ 0\\.008121655543559496\ \(0\)\
\-\ involved\\:\\ 0\\.008109524450479438\ \(0\)\
\-\ adenoma\\:\\ 0\\.008073516633045277\ \(0\)\
\-\ levels\\:\\ 0\\.007980206772108514\ \(0\)\
\-\ nodule\\:\\ 0\\.007968809048058838\ \(0\)\
\-\ located\\:\\ 0\\.007957468455697878\ \(0\)\
\-\ free\\:\\ 0\\.007957468455697878\ \(0\)\
\-\ family\\:\\ 0\\.007923783812046857\ \(0\)\
\-\ 25\\:\\ 0\\.007814991534518265\ \(0\)\
\-\ lymph\\:\\ 0\\.0078043945903725044\ \(0\)\
\-\ removal\\:\\ 0\\.007621676588914453\ \(0\)\
\-\ vs\\:\\ 0\\.007611945634390945\ \(0\)\
\-\ rate\\:\\ 0\\.007535568982977021\ \(0\)\
\-\ change\\:\\ 0\\.007535568982977021\ \(0\)\
\-\ \\<\\:\\ 0\\.0074616867138049565\ \(0\)\
\-\ skin\\:\\ 0\\.007425631075201308\ \(0\)\
\-\ 8\\:\\ 0\\.007228772756220246\ \(0\)\
\-\ intact\\:\\ 0\\.007101277424656599\ \(0\)\
\-\ since\\:\\ 0\\.007101277424656599\ \(0\)\
\-\ wbc\\:\\ 0\\.0070476806574113395\ \(0\)\
\-\ malignant\\:\\ 0\\.006987942706740501\ \(0\)\
\-\ required\\:\\ 0\\.006958655004043584\ \(0\)\
\-\ muscle\\:\\ 0\\.0069441521118243105\ \(0\)\
\-\ weight\\:\\ 0\\.0069297415953413245\ \(0\)\
\-\ then\\:\\ 0\\.006880015562040927\ \(0\)\
\-\ biopsy\\:\\ 0\\.006859034483341088\ \(0\)\
\-\ girl\\:\\ 0\\.006797234006764249\ \(0\)\
\-\ labs\\:\\ 0\\.006723923092613436\ \(0\)\
\-\ benign\\:\\ 0\\.006672059653921271\ \(0\)\
\-\ fever\\:\\ 0\\.006541318159619833\ \(0\)\
\-\ \\(\\:\\ 0\\.006537210192252132\ \(0\)\
\-\ followed\\:\\ 0\\.0064816196185040085\ \(0\)\
\-\ size\\:\\ 0\\.0064816196185040085\ \(0\)\
\-\ \\)\\:\\ 0\\.006457354679758417\ \(0\)\
\-\ swelling\\:\\ 0\\.006440748561043287\ \(0\)\
\-\ radiation\\:\\ 0\\.006344459840638771\ \(0\)\
\-\ follow\\-up\\:\\ 0\\.006289676451225661\ \(0\)\
\-\ body\\:\\ 0\\.006278877178029604\ \(0\)\
\-\ any\\:\\ 0\\.006087862065774421\ \(0\)\
\-\ days\\:\\ 0\\.005925507457402664\ \(0\)\
\-\ usually\\:\\ 0\\.005870878402413482\ \(0\)\
\-\ to\\:\\ 0\\.005797304639497551\ \(0\)\
\-\ evaluation\\:\\ 0\\.005615924877436217\ \(0\)\
\-\ loss\\:\\ 0\\.0056119098924625336\ \(0\)\
\-\ lymphoma\\:\\ 0\\.00552533627689929\ \(0\)\
\-\ all\\:\\ 0\\.00546815269102102\ \(0\)\
\-\ y\\/o\\:\\ 0\\.005354364320858916\ \(0\)\
\-\ history\\:\\ 0\\.005340337274692686\ \(0\)\
\-\ high\\:\\ 0\\.005290828192481484\ \(0\)\
\-\ trauma\\:\\ 0\\.0052873501849726905\ \(0\)\
\-\ cell\\:\\ 0\\.0052222640533517795\ \(0\)\
\-\ cm\\:\\ 0\\.005185421081033905\ \(0\)\
\-\ prior\\:\\ 0\\.0049640560457067055\ \(0\)\
\-\ symptoms\\:\\ 0\\.004818229585742397\ \(0\)\
\-\ acute\\:\\ 0\\.00477348264503732\ \(0\)\
\-\ increased\\:\\ 0\\.004729603578732253\ \(0\)\
\-\ pain\\:\\ 0\\.004722208902854004\ \(0\)\
\-\ soft\\:\\ 0\\.004707979104057806\ \(0\)\
\-\ surgery\\:\\ 0\\.00469456801891465\ \(0\)\
\-\ chest\\:\\ 0\\.004626083710537373\ \(0\)\
\-\ associated\\:\\ 0\\.004562132493003851\ \(0\)\
\-\ \\%\\:\\ 0\\.004509776093543004\ \(0\)\
\-\ other\\:\\ 0\\.004456195811544002\ \(0\)\
\-\ large\\:\\ 0\\.004227471565228688\ \(0\)\
\-\ after\\:\\ 0\\.0040000027208353\ \(0\)\
\-\ treatment\\:\\ 0\\.003913160542083455\ \(0\)\
\-\ is\\:\\ 0\\.0038164532469551512\ \(0\)\
\-\ and\\:\\ 0\\.0036653417456786563\ \(0\)\
\-\ by\\:\\ 0\\.003219164939468043\ \(0\)\
\-\ disease\\:\\ 0\\.0031600396860083806\ \(0\)\
\-\ in\\:\\ 0\\.0028601621955220923\ \(0\)\
\-\ a\\:\\ 0\\.0026918538584972938\ \(0\)\
\-\ are\\:\\ 0\\.0026354612500669723\ \(0\)\
\-\ was\\:\\ 0\\.0022359219959585674\ \(0\)\
\-\ this\\:\\ 0\\.0021745185821586722\ \(0\)\
\-\ left\\:\\ 0\\.002163134093377635\ \(0\)\
\-\ of\\:\\ 0\\.002108666077791646\ \(0\)\
\-\ for\\:\\ 0\\.0016495659471554643\ \(0\)\
\-\ on\\:\\ 0\\.0016377624714149959\ \(0\)\
\-\ \\.\\:\\ 0\\.0013653667729748569\ \(0\)\
\-\ the\\:\\ 0\\.0006255623742245512\ \(0\)\
\-\ with\\:\\ 0\\.0005294306610402251\ \(0\)\
